Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 187 publications
APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial.
Journal: JCO precision oncology
Published: August 21, 2026
Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.
Journal: Journal for immunotherapy of cancer
Published: July 08, 2026
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.
Journal: Journal for immunotherapy of cancer
Published: March 13, 2026
EMBARK in biochemically recurrent prostate cancer: a journey for some but not most.
Journal: The oncologist
Published: December 10, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 23, 2025
Therapeutic targeting of prostate-specific membrane antigen could limit its potential as benchmark imaging.
Journal: Nature reviews. Urology
Published: October 14, 2025
Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel.
Journal: Cancer
Published: October 01, 2025
Ominous-appearing serosal findings on PSMA imaging might belie indolent clinical course.
Journal: Nature reviews. Urology
Published: August 20, 2025
Pembrolizumab in recurrent or metastatic medullary thyroid cancer.
Journal: The oncologist
Published: August 14, 2025
A phase 2 study of GI-6207 in patients with recurrent medullary thyroid cancer.
Journal: The oncologist
Published: August 14, 2025
Castration Resistance Accelerates Prostate Cancer Kinetics.
Journal: The Prostate
Published: August 07, 2025
Prostate Cancer Immunotherapy: Time to Move Beyond Checkpoint Inhibitors.
Journal: ImmunoTargets and therapy
Published: June 27, 2025
Last Updated: 09/26/2026